Outcomes of mTORi-involving minimized immunosuppression
protocols in renal transplantation

dc.contributor.author	Emin Demir, Mehmet
dc.contributor.author	Uyar, Murathan
dc.contributor.author	Merhametsiz, Özgür
dc.contributor.author	Sevmiş, Murat
dc.contributor.author	Aktas, Sema
dc.contributor.author	Sevmiş, Şinasi
dc.date.accessioned	2021-12-21T08:31:06Z
dc.date.available	2021-12-21T08:31:06Z
dc.date.issued	2021
dc.identifier.issn	2636-8579
dc.identifier.uri	https://app.trdizin.gov.tr/makale/TkRNek5qRTRPQT09/outcomes-of-mtori-involving-minimized-immunosuppression-protocols-in-renal-transplantation
dc.identifier.uri	https://doi.org/10.32322/jhsm.835670
dc.identifier.uri	http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/565
dc.description.abstract	Aim: Immunosuppression lowering protocols are commonly involving low-dose calcineurin inhibitors (CNIs) and themammalian target of Rapamycin inhibitor (mTORi). In renal transplant (RT) recipients, due to various factors (thedevelopment of polyoma B-K viru
dc.language.iso	English
dc.title	Outcomes of mTORi-involving minimized immunosuppression protocols in renal transplantation
dc.relation.journal	Journal of health sciences and medicine (Online)
dc.identifier.issue	1
dc.identifier.startpage	71
dc.identifier.endpage	77
dc.identifier.volume	4
dc.identifier.doi	10.32322/jhsm.835670
dc.relation.issue	1
dc.relation.volume	4